Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].

导出 LinkOut

翻译打印收藏纠错

作者： Mitchell D,Creinin ^[1] ; Courtney A,Schreiber ^[2] ; David K,Turok ^[3] ; Carrie,Cwiak ^[4] ; Beatrice A,Chen ^[5] ; Andrea I,Olariu ^[6]

作者单位： Division of Family Planning, Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA. ^[1] Division of Family Planning, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA. ^[2] Division of Family Planning, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT. ^[3] Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA. ^[4] Division of Gynecologic Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, PA. ^[5] Medicines 360, San Francisco, CA. ^[6]

DOI 10.1016/j.ajog.2023.07.011

PMID 37495438

发布时间 2023-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American journal of obstetrics and gynecology

2023年229卷3期

358页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].

American journal of obstetrics and gynecology

相似文献

American journal of obstetrics and gynecology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].

American journal of obstetrics and gynecology

相似文献

American journal of obstetrics and gynecology

相关期刊

检索历史清除